Stratistics MRC report, Peptide Therapeutics Market Forecasts to 2027 – Global Analysis Application, Key Players, Types, End User and By Geography
MARYLAND, GAITHERSBURG, UNITED STATES, October 14, 2021 /EINPresswire.com/ -- The Global Peptide Therapeutics Market is accounted for $28.15 billion in 2019 and is expected to reach $66.76 billion by 2027 growing at a CAGR of 11.4% during the forecast period. Increasing prevalence of cancer, presence of strong product pipeline portfolio and an increasing number of cases of the metabolic disorder is driving the market growth. However, stringent government regulation for the approval process is hampering the growth of the market.
Some of the key players profiled in the Peptide Therapeutics Market include Teva Pharmaceutical, Bachem Holding AG, Sanofi, Pfizer Inc., Amgen Inc., Novartis AG, Lonza Inc., GlaxoSmithKline (GSK), Eli Lilly and Company, Bristol-Myers Squibb(BMS), Merck & Co., AstraZeneca PLC, Novo Nordisk A/S, Ipsen, and Takeda Pharmaceutical Company Limited.
Peptide Therapeutics Market report provides an in-depth study and forecast about the industry covering the complete overview of the market that will assist convey clients and business-making strategies. The industry’s supply chain and market size, in terms of value, have been derived by extensive research methods. Our report enables readers to understand details of the market, latest trends, key drivers and constraints, opportunities, threats, volume and value forecasts, and various investment opportunities for manufacturers operating in the global and regional markets. Peptide Therapeutics Market report also offers company profiling with detailed strategies, financials, key products, and recent developments along with SWOT analysis of profiled players and Porters five forces for deep insights.
This report offers market monitoring related to a particular area of clients interest and provides up to date information related to strategic initiatives like mergers, acquisitions, partnerships, expansions, product launches for leading companies on a regional scale depending on the clients subscription period for various industries or markets. Our data is constantly updated and revised by team of research experts so that it always reflects the recent trends and information. We have high experience in research and consulting for different business domains to provide to the necessities of both individual and corporate clients. Our experienced team uses proprietary data sources and different tools and methods to gather and analyze information.
Type of Molecules Covered:
• Vasopressin
• Somatostatin
• Natriuretic
• Luteinizing Hormone (LH)-Releasing Hormone (LHRH)
• Insulins
• Immunopeptide
• Glucagon and Analogs
• Calcitonin
Browse the latest market research reports by Stratistics MRC:
Practice Management Systems Market Forecasts to 2028 – Global Analysis By Product (Integrated, Standalone), Component (Hardware, Services, Software), End User (Diagnostic Laboratories, Hospitals) and By Geography
Healthcare Analytics Market Forecasts to 2028 – Global Analysis By Type (Predictive, Cognitive), Component (Services, Software), Application (Financial Analytics, Administrative Analytics) and By Geography
Chemiluminescence Immunoassay (CLIA) Analyzers Market Forecasts to 2028 – Global Analysis By Product (Reagents, Analyzer), Application (Allergy, Cardiac Markers, GI Stool Testing, Drug Discovery) and By Geography
About Us:
Stratistics MRC research reports and publications are routed to help clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. We track 30+ industries and cover 800 market segments.
